Literature DB >> 18410281

CNS lymphomatoid granulomatosis with lymph node and bone marrow involvements.

Akihiro Takiyama1, Hiroshi Nishihara, Ukihide Tateishi, Taichi Kimura, Lei Wang, Wang Lei, Katsuji Marukawa, Tomoo Itoh, Satoshi Hashino, Kazuo Nagashima, Shinya Tanaka.   

Abstract

Lymphomatoid granulomatosis (LYG) in the CNS is an uncommon lymphoproliferative disease with characteristic angiocentric lymphoreticular proliferative and granulomatous lesions exhibiting low-grade malignant potential. Here we report a rare case of CNS-LYG, which disseminated to the lymph node and bone marrow. A 50-year-old man was diagnosed with CNS-LYG based on brain biopsy showing perivascular infiltration of CD3-positive small T-lymphocytes without overt nuclear atypism. Eight months after the initial neurological symptoms, inguinal lymph node swelling was found and histopathologically diagnosed as peripheral T-cell lymphoma. TCRgamma-gene rearrangement study using both paraffin-embedded specimens of brain and inguinal lymph node demonstrated an identical clonal band. Considering the clinical course, we concluded lymph node involvement of CNS-LYG, suggesting the malignant potential of CNS-LYG.

Entities:  

Mesh:

Year:  2008        PMID: 18410281     DOI: 10.1111/j.1440-1789.2008.00903.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  2 in total

1.  Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Authors:  Deborah W Sevilla; Erin M Weeden; Suzy Alexander; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  Virchows Arch       Date:  2009-10-06       Impact factor: 4.064

2.  A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings.

Authors:  Hiroshi Nishihara; Matsuyoshi Nakasato; Hiroki Sawa; Hiromi Murakami; Daisuke Yamamoto; Kenji Moriyama; Norifumi Kato; Ikuo Hashimoto; Hajime Kamada; Shinya Tanaka
Journal:  J Neurooncol       Date:  2008-12-23       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.